Wfse, Afscme Council 28 competitors

Christopher D. Hillyer, MD, President and CEO and Chief Scientific Officer of New York Blood Center (NYBC), and Professor, Department of Medicine, Weill Cornell Medical College, was previously the endowed Distinguished Service Professor, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, where he served as director of the Emory Center for Transfusion and Cellular Therapies. He is board certified in transfusion medicine, hematology, medical oncology and internal medicine. He is an editor of 12 textbooks including the 16-18th editions of the AABB Technical Manual, and is recognized internationally as an expert in hematology, blood transfusion, and cellular therapies. His book, Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects, has become a primary resource throughout the world. Dr. Hillyer has authored more than 175 articles pertaining to transfusion, stem cells, erythropoiesis, and virology, and has been awarded millions of dollars in research funding from the National Institutes of Health, the CDC, and other agencies. He is a past-president of AABB, a former trustee of the National Blood Foundation, and served as an associate editor of TRANSFUSION.He is the 2014 Emily Cooley Award recipient for his “significant commitment and contributions to the field of transfusion medicine..." and was recognized with two Tiffany Awards from the American Red Cross for his work in Africa. Dr. Hillyer is an architect of NYBC Ventures, co-founder of Transfusion & Transplantation Technologies, Inc. (3Ti), HemeXcel Purchasing Alliance, and HemeXcel Resources, and holds a number of patents related to blood banking and cellular therapies. He has served on a number of for-profit and not-for-profit boards.Dr. Hillyer received his BS from Trinity College with Honors and his MD from the University of Rochester School of Medicine, with postgraduate fellowships in hematology-oncology, transfusion medicine and bone marrow transplantation at Tufts-New England Medical Center in Boston.

James L. Madara, MD, serves as the CEO and executive vice president of the American Medical Association, the nation’s largest physician organization. He holds the academic title of adjunct professor of pathology at Northwestern University. Since taking the reins of the AMA in 2011, Dr. Madara has helped sculpt the organization’s visionary long-term strategic plan. As an extension of this vision, he now also serves as chairman of Health2047 Inc., an independent, design-driven innovation firm based in San Francisco whose mission is to help advance the AMA’s goal of improving the health of the nation. Prior to arriving at the AMA, Dr. Madara spent the first 22 years of his career at Harvard Medical School, receiving both clinical and research training, serving as a tenured professor and as director of the NIH-sponsored Harvard Digestive Diseases Center. Following 5 years as chair of pathology at Emory, Dr. Madara served as dean of the medical school and CEO of the hospitals at the University of Chicago, bringing together the university’s biomedical research, teaching and clinical activities. While there, he oversaw the renewal of the institution’s biomedical campus and engineered significant new affiliations with community hospitals, teaching hospital systems, community clinics and national research organizations. Dr. Madara also served as senior advisor with Leavitt Partners, an innovative health care consulting and private-equity firm founded by former Secretary of Health and Human Services, Mike Leavitt. Having published more than 200 original papers and chapters, Dr. Madara has received both national and international awards, and served as editor-in-chief of the American Journal of Pathology and as president of the American Board of Pathology. In addition to Modern Healthcare consistently naming him as one of the nation’s 50 most influential physician executives, as well as one of the nation’s 100 most influential people in health care, he is a past recipient of a prestigious MERIT Award from the National Institutes of Health. He received the 2011 Davenport Award for lifetime achievement in gastrointestinal disease from the American Physiological Society and the 2011 Mentoring Award for lifetime achievement from the American Gastroenterological Society. Dr. Madara is an elected member of both the American Society of Clinical Investigation and the Association of American Physicians. He also co-chairs the Value Incentives and Systems Innovation Collaborative of the National Academy of Medicine (NAM), and is a member of NAM’s Leadership Consortium for Value & Science-Driven Health Care. Dr. Madara and his wife Vicki have 2 children, Max and Alexis.

I am an advocate and a voice for animals; committed to preserving, defending, and celebrating the bond we share with them. Professionally, I have extensive experience in animal welfare in both a non-profit and municipal capacity primarily in leadership roles throughout the country including New Mexico, Tennessee, Louisiana, and Michigan.